COVID-19

The FDA granted an Emergency Use Authorization for the drug in hospitalized patients with severe COVID-19, but the authorization does not take the place of a formal new drug approval process.

Consider these 5 takeaways from a pharmacy leader in an academic health care system during the COVID-19 crisis.

A new law approved in Minnesota this week expands pharmacists’ authority by allowing them to administer FDA-authorized COVID-19 or SARS-CoV-2 vaccines when they become available.

Treatment of COVID-19 with both hydroxychloroquine and azithromycin also was strongly associated with increased risk of death.

Pharmacy Times® interviewed James Krellenstein, co-Founder, PrEP4All Collaboration and Organizer, The COVID-19 Working Group, to discuss the development of PrEP for the COVID-19 pandemic.

New York Governor Andrew Cuomo announced last week that New York will launch a COVID-19 testing pilot program with a goal of conducting 7000 tests per week.

A study released today demonstrated that tocilizumab has been shown to significantly improve survival outcomes for patients with COVID-19.

Pharmacists are routinely putting others ahead of themselves and may not be sure how to find time for self-care.

Pharmacy Times spoke with Ron Lanton III, Esq, a regulatory and government affairs professional, about how COVID-19 could lead to more expanded practice laws for pharmacists across the country.

As we consider the implications of the COVID-19 pandemic and the release of remdesivir, ICER’s expedited evaluation raises some questions related to value-based pricing evaluations.

Although most children admitted to pediatric ICUs for COVID-19 had underlying conditions, children, teens, and young adults are at a greater risk for severe complications than researchers had previously believed.

Haziness around the volume of products and locations of facilities hampers management of shortages, experts say.

Four case studies about skin and eye health.

Elizabeth Skoy, PharmD and Amy Werremeyer, PharmD, BCPP, discuss what patients wish their pharmacists knew about mental health.

Because of continuing social distancing policies and stay-at-home orders, many families have been unable to grieve their family members at funerals or other family gatherings.

Top news of the week from Pharmacy Times® surrounding the novel coronavirus.

Mental health first aid trains participants to recognize risk factors and warning signs for mental health and addiction concerns.

The online resource center will host a webinar series and provide comprehensive coverage and updates on COVID-19 through Pharmacy Times®.

John Beckner, RPh, Senior Director of Strategic Initiatives at NCPA, discusses the role of the community pharmacy in the age of COVID-19 in supporting current health care efforts, such as continuing immunizations and managing the effects of the pandemic on patients.

The Secretary of HHS, Alex M. Azar II, clarified in a statement that the PREP Act preempts state licensing laws that place restrictions on pharmacists’ ability to order and administer COVID-19 tests.

Nearly 30% of the 2773 patients with COVID-19 received systemic coagulation during their time in the hospital.

The prescription drug is indicated for facilitating tracheal intubation, and to provide skeletal muscle relaxation during surgery or mechanical ventilation.

As states begin to consider reopening businesses around the country, questions remain for pharmacies regarding appropriate strategies to protect the communities they serve from COVID-19.

Patients with COVID-19 between the ages of 20 and 59 years who also had asthma needed a ventilator to assist with breathing for 5 days more on average than non-asthmatic patients with COVID-19, according to a press release.

The FDA and Aetion have announced an agreement to collaborate on advanced analytical techniques in an effort to answer urgent research questions about COVID-19.

According to an NIH press release, researchers will analyze the medical records of up to 21,000 women to evaluate whether changes to health care delivery that were implemented as a result of the pandemic have led to higher rates of pregnancy-related complications and cesarean delivery.

Positive interim clinical data of the mRNA-1273 vaccine (Moderna, Inc) against the coronavirus disease 2019 were reported from a phase 1 study led by the National Institute of Allergy and Infectious Diseases.

To support the successful reopening of the country in a manner that prevents further COVID-19 outbreaks, the NACDS has issued a report in which it urges government action on 3 key objectives.

A harmonized and collaborative approach to coronavirus disease 2019 (COVID-19) vaccine research and development is necessary for a successful outcome.

With states reopening, pharmacies need to implement controls that will not only protect the safety and health of their employees, but also their patients.